Uruguay bans sales of medicine containing rofecoxib
78199
The Uruguayan government has decided to ban the sales of medicine containing rofecoxib, which is used against arthritis and severe pain, local media reported Saturday.
627905
Doctors who led three studies  showing prescription painkillers called COX-2 inhibitors raise  the risk of heart attacks and stroke said on Tuesday the whole  class of drugs was in danger of being pulled from the market.
90394
A warning is out from the Food and Drug Administration about the pain killer Aleve. The FDA says people taking the over-the-counter medication should strictly follow the directions on the label.
573622
FRIDAY, Oct. 8 (HealthDayNews) -- A week after drug giant Merck & Co. withdrew its arthritis drug Vioxx from the market, doubts are being raised about the safety of the two other approved medications in this class, Bextra and Celebrex.
652888
The European Commission has ordered a full-scale probe into the safety of five remaining Cox-2 arthritis drugs, following last month's worldwide withdrawal of Merck & Co Inc.'s Vioxx.
688234
NEW YORK -- Drug maker Pfizer said yesterday it would immediately stop advertising its best-selling arthritis pain reliever Celebrex to consumers after a study showed high doses of it were associated with an increased heart attack risk.
634546
China's drug watchdog announced Saturday it has suspended the sale of a drug used to treat acute leukemia and rheumatoid arthritis in the latest move to hit the country's scandal-ridden drug industry.
60479
Companies have 60 days to stop selling unapproved prescription drugs made with quinine and dispensed by the millions each year.
290376
A popular painkiller is being withdrawn from the market over concerns about links with overdoses.
4299
BEIJING, Dec. 22 -- The Chinese State Food and Drug Administration (SFDA) advised patients to be cautious when using the drug Celebrex for treating osteoarthritis.
302680
Consumers are advised that all over-the-counter pain medications should be used only as the label directs. While Celebrex and Bextra remain on the market, Merck recently withdrew its COX-2 Vioxx because of the increased risk of cardiovascular events.
364747
THURSDAY, Dec. 23 (HealthDayNews) --  The U.S. Food and Drug Administration says it will review all prevention trials involving the prescription pain medications Celebrex and Bextra. These drugs are part of a category of drugs known as Cox-2 inhibitors.
157889
Description: Pfizer will stop advertising the painkiller Celebrex after discussions with the Food and Drug Administration. A study linked Celebrex to an increased risk of heart problems, but the company plans to keep it on the market.
579429
Novartis AG, Switzerland s largest drugmaker, withdrew an application for European Union approval of its experimental Prexige, a painkiller similar to Merck & Co.
589276
U.S. regulators on Tuesday ordered companies to stop selling unapproved drugs containing quinine, which is approved only in one anti-malaria drug and can have serious side-effects.
115447
The FDA (USA) says it did not try to suppress the findings of a safety official regarding the Vioxx painkiller. Vioxx was taken off the market last week because the drug increases a patient&#39;s risk of having a heart attack.
629337
Chinaâs Ministry of Agriculture said a recent nationwide crackdown on the use of illegal veterinary drugs improved the quality and safety of seafood production.